PharmaResources (Shanghai) Co., Ltd.

SZSE:301230 Stock Report

Market Cap: CN¥3.4b

PharmaResources (Shanghai) Future Growth

Future criteria checks 5/6

PharmaResources (Shanghai) is forecast to grow earnings and revenue by 50.8% and 20.9% per annum respectively. EPS is expected to grow by 51.1% per annum. Return on equity is forecast to be 7% in 3 years.

Key information

50.8%

Earnings growth rate

51.1%

EPS growth rate

Life Sciences earnings growth31.7%
Revenue growth rate20.9%
Future return on equity7.0%
Analyst coverage

Low

Last updated22 Jun 2024

Recent future growth updates

No updates

Recent updates

PharmaResources (Shanghai) Co., Ltd.'s (SZSE:301230) P/S Is Still On The Mark Following 39% Share Price Bounce

Oct 10
PharmaResources (Shanghai) Co., Ltd.'s (SZSE:301230) P/S Is Still On The Mark Following 39% Share Price Bounce

PharmaResources (Shanghai) (SZSE:301230) Posted Weak Earnings But There Is More To Worry About

May 02
PharmaResources (Shanghai) (SZSE:301230) Posted Weak Earnings But There Is More To Worry About

Earnings and Revenue Growth Forecasts

SZSE:301230 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202682594N/A1411
12/31/202567672N/A981
12/31/202456164N/A251
9/30/20245147-127-11N/A
6/30/202451821-140-37N/A
3/31/202449926-18017N/A
12/31/202349038-22721N/A
9/30/202351475-15481N/A
6/30/202351180-17292N/A
3/31/202349672-9985N/A
1/1/202347967-2599N/A
9/30/202248572-5122N/A
6/30/20224657241127N/A
3/31/20224587336122N/A
1/1/20224487413105N/A
9/30/202137748-166N/A
12/31/2020283492154N/A
12/31/201924547741N/A
6/30/2019171302036N/A
3/31/2019149191327N/A
12/31/20181268618N/A
9/30/201812710420N/A
6/30/201812711N/A23N/A
3/31/201813116N/A26N/A
12/31/201713520N/A29N/A
9/30/201713120N/A26N/A
6/30/201712719N/A24N/A
3/31/201711716N/A23N/A
12/31/201610714N/A22N/A
9/30/20169511N/A13N/A
6/30/2016849N/A3N/A
3/31/2016807N/A1N/A
1/1/2016766N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 301230's forecast earnings growth (50.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 301230's earnings (50.8% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 301230's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 301230's revenue (20.9% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 301230's revenue (20.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 301230's Return on Equity is forecast to be low in 3 years time (7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y